Evidence map›Paper›PMID 33493677›Full record

ReviewDrug discovery today2021

SARS-CoV-2 Mediated Hyperferritinemia and Cardiac Arrest: Preliminary Insights.

Prakash VasanthiDharmalingam, Vengadeshprabhu Karuppagounder, Kenichi Watanabe, Harry Karmouty-Quintana, Suresh S Palaniyandi, Ashrith Guha, Rajarajan A Thandavarayan

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Drug discovery today, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Covid-19 and development of heart failure: mystery and truth.Naunyn-Schmiedeberg's archives of pharmacology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Prakash VasanthiDharmalingamClone Gene Biosystems, Chennai, 600 018 Tamil Nadu, India.
Vengadeshprabhu KaruppagounderCenter for Orthopedic Research and Translational Sciences, Department of Orthopedics and Rehabilitation, Penn State College of Medicine, Hershey, 17033 PA, USA.
Kenichi WatanabeDepartment of Laboratory Medicine and Clinical Epidemiology for Prevention of Noncommunicable Diseases, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori Chuo-ku, Niigata 951-8510, Japan.
Harry Karmouty-QuintanaDepartment of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Suresh S PalaniyandiDivision of Hypertension and Vascular Research, Henry Ford Health System, Detroit, MI 48202, USA.
Ashrith GuhaHouston Methodist DeBakey Heart & Vascular Center, 6550 Fannin Street, Houston, TX 77030, USA.
Rajarajan A ThandavarayanHouston Methodist DeBakey Heart & Vascular Center, 6550 Fannin Street, Houston, TX 77030, USA. Electronic address: ramirthalingamthandavarayan@houstonmethodist.org.
Houston Methodist · USHenry Ford Health System · USNiigata University Medical and Dental Hospital · JPPennsylvania State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBiomarkersCOVID-19COVID-19 Drug TreatmentFerritinsHeart ArrestHumansHyperferritinemiaIron Chelating AgentsPrognosisSARS-CoV-2BiomarkersFerritinsIron Chelating Agents

Identifiers

PMID33493677
PMCPMC7826001
OpenAlexW3122313159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.